These results verified the advantages of tumor-infiltrating CD38+ CD8+ T cells in IFN-γ and Granzyme B secretion than tumor-infiltrating CD38− CD8+ T cells in fully activated condition. This evidence concerns the gene CD38 and neoplasm.